220 results on '"Thalmann, G"'
Search Results
2. Impact of the timing of early recurrences during the blanking period in patients after cryoballoon ablation: insights from the COMPARE CRYO study using continuous rhythm monitoring
3. Durability of pulmonary vein isolation with pulsed field ablation compared to radiofrequency ablation in patients with persistent atrial fibrillation: results from a prospective remapping study
4. Scar tissue characterization to predict arrhythmia recurrence in patients undergoing ventricular tachycardia ablation: cardiac computed tomography compared with cardiac magnetic resonance
5. Consistencies in follow-up after radical cystectomy for bladder cancer: A practice-based framework by collaborative EAU bladder cancer guideline panels
6. Characterization of the tumor microenvironment in prostate cancer progression
7. Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multi-centre retrospective study
8. Das akute Skrotum
9. Establishment and application of patient-derived organoids as a functional system to assess therapy response in bladder cancer
10. New generation mTOR blocker sensitizes prostate cancer models to AR-targeting therapy
11. Studying the role of cancer-associated fibroblasts in advanced prostate cancer
12. Tumor heterogeneity and drug sensitivity modelled in primary prostate cancer organoids
13. Investigating key molecular players in putative stem cell subpopulations of prostate cancer
14. Das akute Skrotum
15. Instillationstherapien beim Urothelkarzinom des oberen Harntraktes
16. Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial
17. Stylet-driven vs. non-stylet-driven lead implantation for left bundle branch area pacing
18. Screw-in attempts and success rates in left bundle branch area pacing lead implantation
19. Pulsed-field- vs. cryo- vs. radiofrequency ablation: one-year recurrence rates after pulmonary vein isolation in patients with paroxysmal atrial fibrillation
20. Pulmonary vein reconnection rates and lesion regression during repeat procedures in patients with recurrent arrhythmias after pulsed field ablation pulmonary vein isolation
21. Acute procedural outcomes of left bundle branch area pacing compared to His-bundle pacing
22. Initial experience and early outcomes of posterior wall ablation using pulsed-field ablation
23. Pulsed-field ablation for redo procedures after failed radiofrequency or cryo ablation for atrial fibrillation
24. Therapiemanagement des stumpfen Hodentraumas
25. Prognostic and Predictive Performance of a 24-Gene Post-Operative Radiation Therapy Outcomes Score (PORTOS) in a Phase 3 Randomized Trial of Dose-Intensified Salvage Radiotherapy after Radical Prostatectomy (SAKK 09/10)
26. MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor
27. Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
28. Einführung und Übersicht zur urologischen Bildgebung
29. Validation of a multipolar pulsed field ablation catheter for endpoint assessment in pulmonary vein isolation procedures
30. A genetically engineered mouse model to study oncofetal CRIPTO in aggressive lethal prostate cancer
31. Application of a new 3D culture system to culture uniformly sized patient-derived bladder cancer (BLCa) organoids
32. Identifying drug sensitivity of multifocal primary prostate cancer
33. Exploring the role of androgen signaling in prostate cancer stroma
34. Performance of a Genomic Classifier (GC) Within a Phase 3 Randomized Trial of Dose Escalated Salvage Radiotherapy (SRT) After Radical Prostatectomy (RP)
35. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma
36. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy
37. Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
38. LB05 - Studying the role of cancer-associated fibroblasts in advanced prostate cancer
39. LB08 - Tumor heterogeneity and drug sensitivity modelled in primary prostate cancer organoids
40. UP28 - Investigating key molecular players in putative stem cell subpopulations of prostate cancer
41. UP29 - New generation mTOR blocker sensitizes prostate cancer models to AR-targeting therapy
42. Simulation in urological training and Education (SIMULATE): A randomised controlled clinical and educational trial to determine the effect of simulation-based surgical training
43. Results of a phase II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin (BCG) VPM1002BC in patients with BCG failure - SAKK 06/14
44. The influence of forced diuresis on detection rate in 68 Ga-PSMA-11 PET/CT in recurrent PC: an intra-patient analysis
45. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees
46. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
47. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†
48. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort:under the auspices of the EAU and ESMO Guidelines Committees†
49. 569 - Can orthotopic bladder substitution be performed in patients with positive biopsies of the distal prostatic urethra (male) or the bladder neck (female)?
50. Fortgeschrittenes Prostatakarzinom: Wohin gehen wir?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.